Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes
Background. Diabetes mellitus is a global health problem representing the fifth leading cause of mortality and a major risk factor for cardiovascular diseases. In the last years, we reported an association among urinary trypsin inhibitor (UTI), a small proteoglycan that plays pleiotropic roles in ma...
Saved in:
Main Authors: | Antonio Junior Lepedda, Gabriele Nieddu, Silvia Rocchiccioli, Nadia Ucciferri, Michela Idini, Pierina De Muro, Marilena Formato |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2018/9378515 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus
by: Pierina De Muro, et al.
Published: (2016-01-01) -
Chitosan Hydrogels for Chondroitin Sulphate Controlled Release: An Analytical Characterization
by: Annalisa Bianchera, et al.
Published: (2014-01-01) -
Chondroitin Sulphate-Chitosan Based Nanogels Loaded with Naringenin-β-Cyclodextrin Complex as Potential Tool for the Treatment of Diabetic Retinopathy: A Formulation Study
by: Zucca G, et al.
Published: (2025-01-01) -
Evaluation of the binding affinity and antioxidant activity of phlorizin to pepsin and trypsin
by: Jing Zhang, et al.
Published: (2024-01-01) -
STORAGE OF PIGLET KIDNEYS AT SUBNORMAL TEMPERATURES FOR PRIMARY TRYPSINIZED CELL MONOLAYER PREPARATION
by: B. L. Manin, et al.
Published: (2019-01-01)